HPV検査・PAP検査の世界市場2022-2027:産業動向、シェア、規模、成長、機会・予測

◆英語タイトル:HPV Testing and PAP Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

IMARCが発行した調査報告書(IMARC22NV0172)◆商品コード:IMARC22NV0172
◆発行会社(リサーチ会社):IMARC
◆発行日:2022年8月
◆ページ数:145
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,499 ⇒換算¥374,850見積依頼/購入/質問フォーム
Five UserUSD3,499 ⇒換算¥524,850見積依頼/購入/質問フォーム
EnterprisewideUSD4,499 ⇒換算¥674,850見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

IMARC社の本市場調査資料では、2021年におよそ37.3億ドルであった世界のHPV検査・PAP検査市場規模が2027年53.7億ドルに達し、2022年から2027年の間に年平均6.10%成長すると予測しています。本書では、HPV検査・PAP検査の世界市場について調査し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、検査種類別(HPV検査、PAP検査、共同検査)分析、製品別(機器、消耗品、サービス)分析、用途別(子宮頸がん検診、膣がん検診)分析、エンドユーザー別(病院・クリニック、実験室、診断センタ、その他)分析、地域別(北米、アジア太平洋、ヨーロッパ、中南米、中東/アフリカ)分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などを整理しております。本書では、Abbott Laboratories、Arbor Vita Corporation、AstraZeneca plc、Becton Dickinson and Company、Biocon Limited、bioMérieux SA、Danaher Corporation、F. Hoffmann-La Roche AG、Hologic Inc.、NURX Inc.(Thirty Madison Inc.)などの企業情報が含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション

・世界のHPV検査・PAP検査市場規模:検査種類別
- HPV検査の市場規模
- PAP検査の市場規模
- 共同検査の市場規模

・世界のHPV検査・PAP検査市場規模:製品別
- HPV検査・PAP検査機器の市場規模
- HPV検査・PAP検査消耗品の市場規模
- HPV検査・PAP検査サービスの市場規模

・世界のHPV検査・PAP検査市場規模:用途別
- 子宮頸がん検診における市場規模
- 膣がん検診における市場規模

・世界のHPV検査・PAP検査市場規模:エンドユーザー別
- 病院・クリニックにおける市場規模
- 実験室における市場規模
- 診断センタにおける市場規模
- その他エンドユーザーにおける市場規模

・世界のHPV検査・PAP検査市場規模:地域別
- 北米のHPV検査・PAP検査市場規模
- アジア太平洋のHPV検査・PAP検査市場規模
- ヨーロッパのHPV検査・PAP検査市場規模
- 中南米のHPV検査・PAP検査市場規模
- 中東/アフリカのHPV検査・PAP検査市場規模

・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況
❖ レポートの概要 ❖

The global HPV testing and PAP test market reached a value of US$ 3.73 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 5.37 Billion by 2027, exhibiting a CAGR of 6.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Human papillomavirus (HPV) is a sexually transmitted infection (STI) that causes cancer of the cervix, oropharynx, penis, and vulva. It can be detected with the support of various tests and procedures, such as HPV and Papanicolaou (PAP) test. These assessments comprise microscopic observation of specimens and cervical, head and neck cancer screening. Amongst these, HPV tests are deployed for assessing the presence of human papillomavirus that precede the development of genital warts, whereas PAP tests are used for determining changes in the cell and the presence of abnormal cells in cervices.

HPV Testing and PAP Test Market Trends:
The increasing prevalence of cervical cancer, especially amongst the adult demographics. due to presence of papillomavirus is facilitating the need for novel, technologically advanced, and cost-effective HPV and PAP screening, which is one of the major factors primarily driving the market growth. In line with this, the introduction of machine-assisted, plasma- and cell-free deoxyribonucleic acid (DNA) screenings to detect and monitor the treatment response of HPV-infected cancers at the early phase is acting as another growth-inducing factor. This is further supported by the continuous clinical trials, developments, and product launches by key players, such as the easy-to-use home HPV screening test, on account of the sudden outbreak of coronavirus disease (COVID-19) pandemic, is providing them with a competitive edge in the market. Other factors, such as the rapid expansion in the healthcare sector and the numerous favorable initiatives undertaken by the government bodies and the non-governmental organizations (NGOs) for sensitizing people regarding the causes of cervical cancer and the benefits of having HPV and PAP tests are creating a positive outlook for the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global HPV testing and PAP test market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on test type, product, application and end user.

Breakup by Test Type:

HPV Test
Pap Test
Co-testing

Breakup by Product:

Instruments
Consumables
Services

Breakup by Application:

Cervical Cancer Screening
Vaginal Cancer Screening

Breakup by End User:

Hospitals and Clinics
Laboratories
Diagnostic Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, AstraZeneca plc, Becton Dickinson and Company, Biocon Limited, bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., NURX Inc. (Thirty Madison Inc.), Qiagen N.V., Quest Diagnostics Incorporated, Seegene Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:
How has the global HPV testing and PAP test market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global HPV testing and PAP test market?
What are the key regional markets?
What is the breakup of the market based on the test type?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global HPV testing and PAP test market and who are the key players?
What is the degree of competition in the industry?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global HPV Testing and PAP Test Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Test Type
6.1 HPV Test
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Pap Test
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Co-testing
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Product
7.1 Instruments
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Consumables
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Services
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Cervical Cancer Screening
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Vaginal Cancer Screening
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Diagnostic Centers
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Arbor Vita Corporation
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 AstraZeneca plc
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Becton Dickinson and Company
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Biocon Limited
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 bioMérieux SA
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Danaher Corporation
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 F. Hoffmann-La Roche AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Hologic Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 NURX Inc. (Thirty Madison Inc.)
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Qiagen N.V.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Quest Diagnostics Incorporated
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.13 Seegene Inc.
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.14 Thermo Fisher Scientific Inc.
15.3.14.1 Company Overview
15.3.14.2 Product Portfolio
15.3.14.3 Financials
15.3.14.4 SWOT Analysis

Figure 1: Global: HPV Testing and PAP Test Market: Major Drivers and Challenges
Figure 2: Global: HPV Testing and PAP Test Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: HPV Testing and PAP Test Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: HPV Testing and PAP Test Market: Breakup by Test Type (in %), 2021
Figure 5: Global: HPV Testing and PAP Test Market: Breakup by Product (in %), 2021
Figure 6: Global: HPV Testing and PAP Test Market: Breakup by Application (in %), 2021
Figure 7: Global: HPV Testing and PAP Test Market: Breakup by End User (in %), 2021
Figure 8: Global: HPV Testing and PAP Test Market: Breakup by Region (in %), 2021
Figure 9: Global: HPV Testing and PAP Test (HPV Test) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: HPV Testing and PAP Test (HPV Test) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: HPV Testing and PAP Test (Pap Test) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: HPV Testing and PAP Test (Pap Test) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: HPV Testing and PAP Test (Co-testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: HPV Testing and PAP Test (Co-testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: HPV Testing and PAP Test (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: HPV Testing and PAP Test (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: HPV Testing and PAP Test (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: HPV Testing and PAP Test (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: HPV Testing and PAP Test (Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: HPV Testing and PAP Test (Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: HPV Testing and PAP Test (Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: HPV Testing and PAP Test (Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: HPV Testing and PAP Test (Diagnostic Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: HPV Testing and PAP Test (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: HPV Testing and PAP Test (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: HPV Testing and PAP Test (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: North America: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: North America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: United States: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: United States: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Canada: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Canada: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Asia-Pacific: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Asia-Pacific: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: China: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: China: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Japan: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Japan: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: India: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: India: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: South Korea: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: South Korea: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Australia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Australia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Indonesia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Indonesia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Europe: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Europe: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Germany: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Germany: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: France: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: France: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: United Kingdom: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: United Kingdom: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Italy: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Italy: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Spain: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Spain: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Russia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Russia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Latin America: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Latin America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Brazil: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Brazil: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Mexico: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Mexico: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Middle East and Africa: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Middle East and Africa: HPV Testing and PAP Test Market: Breakup by Country (in %), 2021
Figure 81: Middle East and Africa: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Global: HPV Testing and PAP Test Industry: SWOT Analysis
Figure 83: Global: HPV Testing and PAP Test Industry: Value Chain Analysis
Figure 84: Global: HPV Testing and PAP Test Industry: Porter's Five Forces Analysis

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ HPV検査・PAP検査の世界市場2022-2027:産業動向、シェア、規模、成長、機会・予測(HPV Testing and PAP Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆